Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Current treatment status and barriers for patients with chronic HCV infection in mainland China: A national multicenter cross-sectional survey in 56 hospitals.

Medicine - 1 Aug 2017

Bian Dan-Dan, Zhou Hai-Yang, Liu Shuang, Liu Mei, Duan Carol, Zhang Jin-Yan, Jiang Ying-Ying, Wang Ting, Chen Yu, Wang Zhao, Zheng Su-Jun, Duan Zhong-Ping

Abstract excerpt

Chronic hepatitis C virus (HCV) infection is a serious public health problem worldwide. China, as the country with the largest number of HCV infections in the world, plays a significant role in eliminating hepatitis C. Due to different financial situations and education background, hepatitis C patients take different actions for their disease treatment and management. Therefore, antiviral treatment status should...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Therapy, Combination
Share to Hepatitis C, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon-alpha

Share to Liver Cirrhosis

Share to Liver Neoplasms

Share to Polyethylene Glycols

Share to Ribavirin

Share to Socioeconomic Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 28834904
DOI: 10.1097/MD.0000000000007885
PMCID: PMC5572026

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Current treatment status and barriers for patients with chronic HCV infection in mainland China: A national multicenter cross-sectional survey in 56 hospitals.PMID 28834904Read ↗

Current challenges and the management of chronic hepatitis C in mainland China.Semantic proximity Read ↗

Urgency to treat patients with chronic hepatitis C in Asia.Semantic proximity Read ↗

[Renewed 2015 Clinical Practice Guidelines for Management of Hepatitis C by Korean Association for the Study of the Liver; What Has Been Changed? - Treatment of Chronic Hepatitis C Genotype 1].Semantic proximity Read ↗

Recent update of the 2017 Korean Association for the Study of the Liver (KASL) treatment guidelines of chronic hepatitis C: Comparison of guidelines from other continents, 2017 AASLD/IDSA and 2016 EASL.Semantic proximity Read ↗

Barriers to treatment of failed or interferon ineligible patients in the era of DAA: single center study.Semantic proximity Read ↗

Are There Still Difficult-to-Treat Patients with Chronic Hepatitis C in the Era of Direct-Acting Antivirals?Semantic proximity Read ↗

Current status of and barriers to liver cancer treatment in China: a questionnaire-based study from the perspective of doctorsSemantic proximity Read ↗

[Renewed 2015 Clinical Practice Guidelines for Management of Hepatitis C by Korean Association for the Study of the Liver; What Has Been Changed? - Treatment of Chronic Hepatitis C Genotype 2 and 3].Semantic proximity Read ↗

Clinical characteristics and current management of hepatitis B and C in China.Semantic proximity Read ↗

[Current status, treatment and prospect of patients with chronic hepatitis C genotype 3 in China].Semantic proximity Read ↗

Final Report of Unmet Needs of Interferon-Based Therapy for Chronic Hepatitis C in Korea: Basis for Moving into the Direct-Acting Antiviral Era.Semantic proximity Read ↗

Chronic hepatitis B virus infection: epidemiology, prevention, and treatment in China.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.